Open AccessIs there a Need to Identify Novel Tumour Antigens as Targets for Immunotherapy Clinical Trials for The Removal of Minimal Residual Disease in Haematological Malignancies?
Author(s) -
Barbara Guinn
Publication year - 2015
Publication title -
international journal of hematology research
Language(s) - English
Resource type - Journals
ISSN - 2409-3548
DOI - 10.17554/j.issn.2409-3548.2015.01.10
Subject(s) - immunotherapy , medicine , minimal residual disease , clinical trial , cancer , cancer immunotherapy , disease , antigen , oncology , tumor associated antigen , active immunotherapy , immunology , leukemia